ARTICLE | Company News
GeneFormatics, Bristol-Myers deal
January 14, 2002 8:00 AM UTC
The companies will develop nuclear magnetic resonance (NMR) software for use in automated, high throughput determination of 3-D protein structures. The companies will cross-license their respective NM...